HDAC9 and coronary artery disorder: When patients were stratified by CAD subtypes, we further observed the significant associations of the AG + AA genotypes with increased levels of HDAC9 mRNA expression and plasma HDAC9 in patients with NSTEMI and STEMI (Fig 2).